Lexeo Therapeutics (LXEO) Enterprise Value (2022 - 2026)
Lexeo Therapeutics (LXEO) reported Enterprise Value of -$193.0 million for Q1 2026, down 93.37% on a YoY basis from -$2.9 billion in Q1 2025, and down 6.2% sequentially from -$181.8 million in Q4 2025.
Lexeo Therapeutics (LXEO) Enterprise Value (2022 - 2026) Analysis & Trends
Lexeo Therapeutics (LXEO) has 5 years of Enterprise Value data on file, last reported at -$193.0 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value fell 93.37% year-over-year to -$193.0 million; the trailing twelve-month figure through Mar 2026 stood at -$193.0 million (down 93.37% YoY), and the FY2025 full-year result was -$181.8 million, down 49.58% from the prior year.
- Enterprise Value declined to -$193.0 million in Q1 2026, from -$181.8 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$35.4 million in Q3 2023 to a low of -$195.1 million in Q1 2024.
- A 5-year average of -$131.3 million and a median of -$122.8 million in 2025 frame the typical range for Enterprise Value.
- Across the five-year window, Enterprise Value surged 62.35% in 2023 and sank 342.89% in 2024, its largest moves.
- Tracing LXEO's Enterprise Value over 5 years: stood at -$77.3 million in 2022, then sank by 57.06% to -$121.5 million in 2023, then fell by 0.04% to -$121.5 million in 2024, then slumped by 49.58% to -$181.8 million in 2025, then declined by 6.2% to -$193.0 million in 2026.
- Business Quant data shows LXEO's Enterprise Value at -$193.0 million in Q1 2026, -$181.8 million in Q4 2025, and -$122.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Lexeo Therapeutics | 382.38 Mn | 382.38 Mn | - | -193.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -193.04 Mn |
| Dec 31, 2025 | -181.77 Mn |
| Sep 30, 2025 | -122.76 Mn |
| Jun 30, 2025 | -132.89 Mn |
| Mar 31, 2025 | -99.83 Mn |
| Dec 31, 2024 | -121.52 Mn |
| Sep 30, 2024 | -157.00 Mn |
| Jun 30, 2024 | -174.98 Mn |
| Mar 31, 2024 | -195.06 Mn |
| Dec 31, 2023 | -121.47 Mn |
| Sep 30, 2023 | -35.45 Mn |
| Dec 31, 2022 | -77.34 Mn |
| Sep 30, 2022 | -94.15 Mn |